SecBot SecBot
Insider Cluster (3 insiders) ·Filed Jun 3, 2026

EVMN

Evommune, Inc.
BEARISH
Impact 5/10
Horizondays Processed4mo ago
Insider cluster: 3 insiders, $1.1M total
Actionable Insight ▼ Bearish

The coordinated C-suite selling at a company with a 94% analyst buy rating and a stock that has been persistently declining is a red flag. The cross-filing amplifiers suggest this cluster is more informative than standalone. Traders should watch for upcoming earnings or material news that could explain the insider exits, and consider reducing long exposure or adding protective puts.

DirectionBearish
Confidencemedium
Horizondays
Final — all horizons settled through T+60d
EVMN ▼ -36.06% at T+60d
SHORT call ✓ call won +36.06% · α vs SPY +37.94% · entry $20.69 → $13.23
Entry = T+0 close
Jun 3, 2026
via day close
T+1d
-3.72%
call +3.72% · α +1.12%
$19.92
settled 5mo ago
T+5d
0.00%
call 0.00% · α -2.55%
$20.69
settled 5mo ago
T+20d
-37.36%
call +37.36% · α +35.99%
$12.96
settled 4mo ago
T+60d
-36.06%
call +36.06% · α +37.94%
$13.23
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Three top executives at Evommune (CEO, CFO, CLO) sold a combined $1.12M in open-market sales over a 5-day window, representing ~0.16% of the $714M market cap. The cluster is modest in size relative to market cap, but the involvement of the entire C-suite in coordinated selling is notable.

Key Financial Metrics

Direction
selling
Total Value
$1.1M
Insiders
3

Key Facts

  • CEO Luis Pena sold $382K in open-market shares on June 1, 2026.
  • CFO Kyle Carver sold $415K in open-market shares on May 28, 2026.
  • CLO Gregory Moss sold $325K in open-market shares on May 28, 2026.
  • Total insider sales of $1.12M represent ~0.16% of the $714M market cap.
  • All three sales were open-market (code S), not tax-withholding or derivative exercises.

Financial Impact

Total insider sales of $1.12M, or ~0.16% of market cap — modest in absolute size but significant given the C-suite coordination.

insider ownershipmarket sentiment

Risk Factors

  • Insiders may be reacting to upcoming negative news (e.g., clinical trial failure, regulatory setback, or earnings miss).
  • Despite 94% analyst bullishness, insider behavior is contradicting the consensus, creating a credibility gap.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-EVMN-1780531355841
15 reports for EVMN
Performance horizon
67% Hit rate @ T+60 2 of 3 directional calls Went positive at some point 2 of 4 best @ T+60▲ +41.15%May 28, 2026
Filters
Rows
Reports for EVMN — sortable, filterable
TypeNow
Oct 1, 2026
25d ago
8-K
BULLISH ★ 7/10
$7.21awaiting T+60—$5.13 (−28.85%)
Sep 15, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$9.99awaiting T+60—$5.13 (−48.65%)
Jul 30, 2026
12w ago
8-K
NEUTRAL ★ 5/10
$11.35 $5.10▼ −55.07%▼ −57.53%$5.13 (−54.80%)
Jul 10, 2026
15w ago
Insider Cluster
NEUTRAL ★ 3/10
$12.10 $6.61▼ −45.37%▼ −49.37%$5.13 (−57.60%)
Jun 29, 2026
17w ago
8-K
BEARISH ★ 7/10
$15.05 $9.60▲ +36.21%▲ +40.60%$5.13 (+65.91%)
Jun 24, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$24.13 $9.65▼ −60.01%▼ −63.74%$5.13 (−78.74%)
Jun 3, 2026
20w ago
Insider Cluster
BEARISH ★ 5/10
$20.69 $13.23▲ +36.06%▲ +37.94%$5.13 (+75.21%)
Jun 2, 2026
20w ago
144
NEUTRAL ★ 3/10
$19.73 $13.48▼ −31.68%▼ −34.18%$5.13 (−74.00%)
Jun 1, 2026
21w ago
Insider Cluster
NEUTRAL ★ 3/10
$19.82 $14.11▼ −28.81%▼ −29.93%$5.13 (−74.12%)
May 28, 2026
21w ago
144
BEARISH ★ 5/10
$23.23 $13.67▲ +41.15%▲ +42.34%$5.13 (+77.92%)
Showing 10 of 15

US Market Status

Market Closed — Opens Wed (10h 36m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 3, 2026